Homocysteine, your heart and the methylation cycle

Most people have never heard of homocysteine, yet a high level is an independent warning sign for heart and vascular disease. The good news is that it is one of the most manageable risk markers, once you know your genetics.

Homocysteine is a cardiovascular red flag

Homocysteine is a by-product of normal metabolism. Kept low, it is harmless; allowed to build up, it is associated with damage to blood vessels and raised cardiovascular risk. Your body is supposed to recycle it continuously.

The methylation cycle clears it

That recycling runs through the methylation cycle, where the genes MTHFR, MTRR and MTR work together with the B-vitamins folate, B12, B6 and B2 to convert homocysteine back into the useful amino acid methionine. Every part of the chain has to work for the level to stay low.

Where genes break the cycle

Reduced-function variants in these genes slow the cycle, so homocysteine can drift upward even with an ordinary diet. Because the genes interact, a weakness in one place is often compensated by getting the B-vitamin forms right.

What actually helps

The targeted support is the active B-vitamins: methylfolate, methyl-B12, B6 and B2, matched to your genotype rather than given blindly. It is one of the clearest cases where the right nutrient forms directly move a hard cardiovascular number.

The science, in depth

Homocysteine is remethylated to methionine via methionine synthase (MTR), which depends on methyl-B12 and on MTRR for reactivation, and on 5-MTHF supplied by MTHFR. Polymorphisms across MTHFR, MTRR and MTR reduce remethylation capacity, raising homocysteine in a genotype- and nutrient-status-dependent way.